Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis

被引:8
作者
Uchida, Yasuki [1 ]
Tsugawa, Takuya [2 ]
Tanaka-Mizuno, Sachiko [3 ,4 ]
Noma, Kazuo [5 ]
Aoki, Ken [2 ]
Shigemori, Wataru [1 ]
Nakagawa, Hiroaki [1 ]
Kinose, Daisuke [1 ]
Yamaguchi, Masafumi [1 ]
Osawa, Makoto [1 ,6 ]
Ogawa, Emiko [1 ,7 ]
Nakano, Yasutaka [1 ]
机构
[1] Shiga Univ Med Sci, Div Resp Med, Dept Internal Med, Otsu, Shiga, Japan
[2] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga, Japan
[3] Shiga Univ Med Sci, Dept Med Stat, Otsu, Shiga, Japan
[4] Shiga Univ, Ctr Data Sci Educ & Res, Hikone, Shiga, Japan
[5] Shiga Univ Med Sci Hosp, Dept Radiol, Otsu, Shiga, Japan
[6] Shiga Univ Med Sci Hosp, Div Infect Control & Prevent, Otsu, Shiga, Japan
[7] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
Radiation pneumonitis; Chronic obstructive pulmonary disease; Low attenuation volume; Dosimetric parameter; Lung cancer; STEREOTACTIC BODY RADIOTHERAPY; OBSTRUCTIVE PULMONARY-DISEASE; HISTOGRAM ANALYSIS; COMPUTED-TOMOGRAPHY; CANCER PATIENTS; BRONCHOALVEOLAR LAVAGE; THERAPY; CHEMORADIATION; ASSOCIATION; PARAMETERS;
D O I
10.1186/s13014-017-0891-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The risk factors for radiation pneumonitis (RP) in patients with chronic obstructive pulmonary disease (COPD) are unclear. Mean lung dose (MLD) and percentage of irradiated lung volume are common predictors of RP, but the most accurate dosimetric parameter has not been established. We hypothesized that the total lung volume irradiated without emphysema would influence the onset of RP. Methods: We retrospectively evaluated 100 patients who received radiotherapy for lung cancer. RP was graded according to the Common Terminology Criteria for Adverse Events (version 4.03). We quantified low attenuation volume (LAV) using quantitative computed tomography analysis. The association between RP and traditional dosimetric parameters including MLD, volume of the lung receiving a dose of >= 2 Gy, >= 5 Gy, >= 10 Gy, >= 20 Gy, and >= 30 Gy, and counterpart measurements of the lung without LAV, were analyzed by logistic regression. We compared each dosimetric parameter for RP using multiple predictive performance measures including area under the receiver operating characteristic curve (AUC) and integrated discrimination improvement (IDI). Results: Of 100 patients, RP of Grades 1, 2, 3, 4, and 5 was diagnosed in 24, 12, 13, 1, and 1 patients, respectively. Compared with traditional dosimetric parameters, counterpart measurements without LAV improved risk prediction of symptomatic RP. The ratio of the lung without LAV receiving >= 30 Gy to the total lung volume without LAV most accurately predicted symptomatic RP (AUC, 0.894; IDI, 0.064). Conclusion: Irradiated lung volume without LAV predicted RP more accurately than traditional dosimetric parameters.
引用
收藏
页数:10
相关论文
共 29 条
  • [1] [Anonymous], 2009, COMM TERM CRIT ADV E
  • [2] BJERMER L, 1990, CANCER RES, V50, P2027
  • [3] BJERMER L, 1993, EUR RESPIR J, V6, P1173
  • [4] Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy
    Fay, M
    Tan, A
    Fisher, R
    Mac Manus, M
    Wirth, A
    Ball, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05): : 1355 - 1363
  • [5] COMPARISON OF COMPUTED DENSITY AND MACROSCOPIC MORPHOMETRY IN PULMONARY-EMPHYSEMA
    GEVENOIS, PA
    DEMAERTELAER, V
    DEVUYST, P
    ZANEN, J
    YERNAULT, JC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) : 653 - 657
  • [6] Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
    Graham, MV
    Purdy, JA
    Emami, B
    Harms, W
    Bosch, W
    Lockett, MA
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 323 - 329
  • [7] Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer
    Hernando, ML
    Marks, LB
    Bentel, GC
    Zhou, SM
    Hollis, D
    Das, SK
    Fan, M
    Munley, MT
    Shafman, TD
    Anscher, MS
    Lind, PA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03): : 650 - 659
  • [8] Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC
  • [9] Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial
    Hoover, Douglas A.
    Capaldi, Dante P. I.
    Sheikh, Khadija
    Palma, David A.
    Rodrigues, George B.
    Dar, A. Rashid
    Yu, Edward
    Dingle, Brian
    Landis, Mark
    Kocha, Walter
    Sanatani, Michael
    Vincent, Mark
    Younus, Jawaid
    Kuruvilla, Sara
    Gaede, Stewart
    Parraga, Grace
    Yaremko, Brian P.
    [J]. BMC CANCER, 2014, 14
  • [10] Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis
    Inoue, Toshihiko
    Shiomi, Hiroya
    Oh, Ryoong-Jin
    [J]. JOURNAL OF RADIATION RESEARCH, 2015, 56 (04) : 727 - 734